Tony's Diary Package — page 59

. Ttaly >31,000 accelerating the clinical trial aspect of Remdesivir. Also, we clearly need to have a discussion with Gilead about drug supply and the plan for any accelerated study. Finally, and importantly, the Chinese already have a clinical trial of Remdesivir with more than 200 people enrolled in the advanced disease arm of the study. Someone should directly contact the Chinese investigators (Bin Cao, et al) and find out if they have any preliminary data on efficacy and safety. In my mind it is imperative that we find out what they know before we launch any distribution program. Happy to discuss. Thanks, Tony Anthony S. Fauci, MD Director National Institute of Allergy and Infectious Diseases Building 31, Room 7A-03 31 Center Drive, MSC 2520 National Institutes of Health Bethesda, MD 20892-2520 Phone: (301) 496-2263 FAX: (301) 496-4409 E-mail: afauci@niaid.nih.gov PRESS: Dave Webb Radio Show; Mike Gallagher Show; FOX Tucker Carlson; CNN Cuomo Prime Time; Mar. 19, 2020 - >200,000/~10,000; USA - 9026/150; 2900 new. Italy >31,000 In the USA testing: ~70,000 tests with ~10% positive Met yet again with POTUS right before the press conference, which did not include me since it was predominantly an FDA issue with Steve Hahn. POTUS excited about making drugs (Chloroquine, Remdesivir, etc.) more accessible. Therapy was the theme of the day. They actually were going to go too far (see above) and make them all available on compassionate use. I convinced them not to. POTUS was hot to give out chloroquine or hydroxychloroquine since Jeff Ellison thinks that it is a great drug. Steve Hahn did a good job in stressing the need for safety and efficacy data. Katie Miller and Kelly Love are trying to not overload me and particularly Katie is sensitive to my time.